Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$0.42 - $0.72 $10,668 - $18,288
-25,400 Reduced 6.28%
379,180 $238,000
Q3 2023

Nov 14, 2023

SELL
$0.6 - $1.53 $46,860 - $119,493
-78,100 Reduced 16.18%
404,580 $242,000
Q2 2023

Aug 15, 2023

BUY
$1.05 - $1.63 $248,476 - $385,729
236,644 Added 96.18%
482,680 $545,000
Q2 2022

Aug 15, 2022

SELL
$2.13 - $9.01 $15,762 - $66,674
-7,400 Reduced 2.92%
246,036 $600,000
Q1 2022

May 13, 2022

BUY
$6.28 - $15.59 $3,366 - $8,356
536 Added 0.21%
253,436 $2.02 Million
Q4 2021

Feb 14, 2022

SELL
$14.7 - $28.67 $529,200 - $1.03 Million
-36,000 Reduced 12.46%
252,900 $3.86 Million
Q3 2021

Nov 10, 2021

SELL
$24.31 - $33.6 $36,465 - $50,400
-1,500 Reduced 0.52%
288,900 $8.21 Million
Q2 2021

Jul 30, 2021

BUY
$26.09 - $40.4 $2.11 Million - $3.27 Million
80,900 Added 38.62%
290,400 $9.8 Million
Q1 2021

May 06, 2021

BUY
$33.06 - $56.93 $1.17 Million - $2.02 Million
35,400 Added 20.33%
209,500 $8.01 Million
Q4 2020

Feb 08, 2021

BUY
$39.09 - $57.4 $58,635 - $86,100
1,500 Added 0.87%
174,100 $7.28 Million
Q3 2020

Nov 12, 2020

SELL
$28.43 - $44.67 $108,034 - $169,746
-3,800 Reduced 2.15%
172,600 $7.48 Million
Q2 2020

Aug 13, 2020

BUY
$11.71 - $30.29 $839,607 - $2.17 Million
71,700 Added 68.48%
176,400 $5.34 Million
Q1 2020

May 14, 2020

SELL
$7.64 - $27.5 $27.1 Million - $97.6 Million
-3,549,476 Reduced 97.13%
104,700 $1.43 Million
Q4 2019

Feb 18, 2020

SELL
$15.02 - $20.57 $14.7 Million - $20.1 Million
-975,696 Reduced 21.07%
3,654,176 $58.9 Million
Q3 2019

Nov 14, 2019

SELL
$18.85 - $27.5 $1.89 Million - $2.76 Million
-100,460 Reduced 2.12%
4,629,872 $89.2 Million
Q2 2019

Aug 14, 2019

BUY
$17.37 - $26.27 $48.9 Million - $74 Million
2,816,122 Added 147.12%
4,730,332 $111 Million
Q1 2019

May 14, 2019

BUY
$10.65 - $25.75 $19.6 Million - $47.5 Million
1,843,810 Added 2619.05%
1,914,210 $44.8 Million
Q3 2018

Nov 08, 2018

BUY
$7.54 - $18.31 $156,078 - $379,017
20,700 Added 41.65%
70,400 $1.18 Million
Q2 2018

Aug 13, 2018

BUY
$4.87 - $8.42 $86,199 - $149,034
17,700 Added 55.31%
49,700 $365,000
Q1 2018

May 14, 2018

BUY
$4.69 - $10.05 $50,652 - $108,540
10,800 Added 50.94%
32,000 $150,000
Q4 2017

Feb 13, 2018

SELL
$7.86 - $9.99 $19,650 - $24,975
-2,500 Reduced 10.55%
21,200 $192,000
Q3 2017

Nov 13, 2017

BUY
$8.89 - $10.4 $210,693 - $246,480
23,700
23,700 $222,000

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.